First and Second Line Antibiotic Treatment for Impetigo
Direct Answer
For limited impetigo, use topical mupirocin 2% ointment three times daily for 5-7 days as first-line treatment; for extensive disease or when oral therapy is needed, use cephalexin 25-50 mg/kg/day divided into 4 doses (or 250-500 mg four times daily in adults) for 7 days as first-line, and clindamycin 20-30 mg/kg/day divided into 3 doses (or 300-450 mg three times daily in adults) for 7 days as second-line, particularly when MRSA is suspected or in penicillin-allergic patients. 1, 2
Treatment Algorithm Based on Disease Extent
Limited Disease (Few Lesions)
- Topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment 1, 3
- Mupirocin achieves clinical efficacy rates of 71-93% compared to 35% for placebo, with pathogen eradication rates of 94-100% 3
- Topical therapy is superior to oral antibiotics for limited disease and has fewer side effects 1, 4
Extensive Disease or When Oral Therapy Required
First-Line Oral Antibiotics:
- Cephalexin 25-50 mg/kg/day divided into 4 doses for 7 days (pediatric) or 250-500 mg four times daily (adult) 1, 2
- Dicloxacillin 25-50 mg/kg/day divided into 4 doses for 7 days (pediatric) or 250 mg four times daily (adult) as an alternative first-line option 1, 2
- Co-amoxiclav (amoxicillin-clavulanate) is an acceptable alternative when cephalexin or dicloxacillin are not suitable 1
Second-Line Oral Antibiotics (for MRSA or penicillin allergy):
- Clindamycin 20-30 mg/kg/day divided into 3 doses for 7 days (pediatric) or 300-450 mg three times daily (adult) 1, 2
- Trimethoprim-sulfamethoxazole (SMX-TMP) 8-12 mg/kg/day divided into 2 doses for 7 days (pediatric) or 1-2 double-strength tablets twice daily (adult) 1, 2
- Doxycycline 2-4 mg/kg/day divided into 2 doses for 7 days (only for children over 8 years old) 1
Critical Considerations for Penicillin Allergy
- Clindamycin is the preferred alternative for penicillin-allergic patients 2
- Avoid cephalosporins (like cephalexin) if the patient has type 1 hypersensitivity reactions (anaphylaxis/hives) to β-lactams 2
- For mild penicillin allergy without anaphylaxis history, cephalexin can be considered as it has low cross-reactivity 1
- Macrolides (erythromycin) can be used but resistance rates are rising 1
When to Switch from Topical to Oral Therapy
Oral antibiotics are indicated when: 1, 2
- Numerous lesions are present (extensive disease)
- Lesions involve the face, eyelid, or mouth
- No improvement after 3-5 days of topical therapy
- Systemic symptoms are present
- During outbreaks to decrease transmission
- Patient cannot comply with topical application
Management of Recurrent Infections
- Obtain cultures from lesions if there is treatment failure, MRSA is suspected, or in cases of recurrent infections 2
- Consider MRSA coverage empirically in areas with high MRSA prevalence until culture results are available 1
- If no improvement by 3-5 days of appropriate therapy, reassess for MRSA infection, deeper infection, non-compliance, or antibiotic resistance 2
- Implement infection control measures: keep lesions covered with clean dry bandages, maintain good hand hygiene, avoid sharing personal items 1, 2
Critical Pitfalls to Avoid
- Never use penicillin or amoxicillin alone for impetigo—they lack adequate coverage against S. aureus, which is now the predominant causative organism 1, 5
- Do not use topical clindamycin cream (designed for acne)—it lacks FDA indication for impetigo and has insufficient bioavailability 2
- Avoid tetracyclines (doxycycline) in children under 8 years due to risk of permanent dental staining 1, 2
- Do not use disinfectant solutions as primary therapy—there is little evidence they improve outcomes 1, 4
- Ensure 7-day duration for oral antibiotics, not the shorter 5-day course used for topical agents 1, 2
Special Populations
- Pregnant patients: Cephalexin is a safe alternative 1, 2
- Immunocompromised patients: Lower threshold for oral antibiotics, monitor closely for treatment failure or deeper infection, consider longer treatment duration 2
- Neonates and infants ≤3 months: Maximum dose is 30 mg/kg/day divided every 12 hours 1